Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

NCT00358098 · clinicaltrials.gov ↗

TERMINATED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Sponsor

AHS Cancer Control Alberta